BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 212377)

  • 21. Multiplicity-dependent induction of viral capsid antigen in Raji cells superinfected with Epstein-Barr virus.
    Fujiwara S; Takada K; Yano S; Osato T
    Virology; 1983 Jul; 128(2):490-4. PubMed ID: 6310870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus-induced proteins. IV. Characterization of an EBV-associated phosphopolypeptide.
    Mueller-Lantzsch N; Yamamoto N
    J Gen Virol; 1981 Aug; 55(Pt 2):333-41. PubMed ID: 6270267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyploidization of Epstein-Barr virus (EBV)-carrying lymphoma lines decreases the inducibility of EBV-determined early antigen following P3HR-1 virus superinfection or iododeoxyuridine treatment.
    Shapiro IM; Andersson-Anvret M; Klein G
    Intervirology; 1978; 10(2):94-101. PubMed ID: 209000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity of Epstein-Barr virus derived from P3HR-1 cells.
    zur Hausen H; Fresen KO
    IARC Sci Publ (1971); 1978; (20):391-6. PubMed ID: 215522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns.
    Klein G; Zeuthen J; Ber R; Ernberg I
    J Natl Cancer Inst; 1982 Feb; 68(2):197-202. PubMed ID: 6278188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential induction of Epstein-Barr virus-related antigens in heterokaryon cultures.
    Yamamoto K; Osato T
    Int J Cancer; 1977 Jun; 19(6):767-74. PubMed ID: 194844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.
    Fresen KO; Hausen H
    Int J Cancer; 1976 Feb; 17(2):161-6. PubMed ID: 175026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV).
    Vestergaard BF; Hesse J; Norrild B; Klein G
    Int J Cancer; 1978 Mar; 21(3):323-8. PubMed ID: 75856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus.
    Lidin BI; Lamon EW
    Arch Virol; 1983; 77(1):13-25. PubMed ID: 6312934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between Epstein-Barr virus (EBV)-production and the loss of the EBV receptor/complement receptor complex in a series of sublines derived from the same original Burkitt's lymphoma.
    Klein G; Yefenof E; Falk K; Westman A
    Int J Cancer; 1978 May; 21(5):552-60. PubMed ID: 207646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody.
    Lin JC; Choi EI; Pagano JS
    J Virol; 1985 Mar; 53(3):793-9. PubMed ID: 2983091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle in a new set of somatic cell hybrids.
    Klein G; Clements G; Zeuthen J; Westman A
    Cancer Lett; 1977 Jul; 3(1-2):91-8. PubMed ID: 196751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Suppressive effect of CDDP on induction of the Epstein-Barr virus antigen synthesis by n-butyrate].
    Furukawa M; Kato C; Kamide M; Umeda R
    Nihon Jibiinkoka Gakkai Kaiho; 1989 Feb; 92(2):189-93. PubMed ID: 2545850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity of Epstein-Barr virus originating from P3HR-1 cells. I. Studies on EBNA induction.
    Fresen KO; Merkt B; Bornkamm GW; Hausen H
    Int J Cancer; 1977 Mar; 19(3):317-23. PubMed ID: 191406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properties of a baboon lymphotropic herpesvirus related to Epstein-Barr virus.
    Falk L; Deinhardt F; Nonoyama M; Wolfe LG; Bergholz C
    Int J Cancer; 1976 Dec; 18(6):798-807. PubMed ID: 186420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interaction of non-transforming Epstein-Barr virus (EBV) with cell-associated EBV DNA in superinfected lymphoblastoid cell lines.
    Stoerker J; Yajima Y; Glaser R
    Int J Cancer; 1982 Oct; 30(4):385-92. PubMed ID: 6292115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA.
    Dillner J; Kallin B; Ehlin-Henriksson B; Timar L; Klein G
    Int J Cancer; 1985 Mar; 35(3):359-66. PubMed ID: 2982749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells with propionic acid and with culture fluids of propionic acid-producing anaerobes.
    Kishishita M; Yanase S; Ito Y
    Cancer Lett; 1982; 16(2):117-20. PubMed ID: 6290028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines.
    Boguszaková L; Hirsch I; Brichácek B; Vonka V
    J Gen Virol; 1983 Apr; 64 (Pt 4)():887-94. PubMed ID: 6300308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of epstein-Barr virus (EBV) of P3HR-1: isolation of EBV with EBNA induction ability in human cord lymphocytes and without EA induction ability in Raji cells.
    Yano S; Tanaka A; Takada K; Fujiwara S; Osato T; Nonoyama M
    Virology; 1982 Jun; 119(2):392-8. PubMed ID: 6281981
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.